Drugs Health Pharma

Novo Nordisk to buy hypertension drug from KBP for $1.3 billion

HQ Team October 16, 2023: Danish pharmaceutical company, Novo Nordisk, announced it was buying a hypertension drug, still in trials, from Singapore-based KBP.

Read More
X